← Open Payments lookup

HOPE MANNING: Open Payments

NPI 1477028793 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,213 in 46 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $1,213

Food & beverage: $763Consulting: $450
CompanyPaymentsAmount
Alkermes, Inc.7$600
ABBVIE INC.14$196
Supernus Pharmaceuticals, Inc.9$111
Otsuka America Pharmaceutical, Inc.5$97
Indivior Inc.3$52
Bausch Health US, LLC2$39
Collegium Pharmaceutical, Inc.1$23
Axsome Therapeutics, Inc.1$23
Corcept Therapeutics1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: VIVITROL, VRAYLAR, Qelbree, REXULTI, SUBLOCADE, ARISTADA, ABILIFY ASIMTUFII, Jornay PM.

Industry payments across CO — which companies pay providers there.